PT233 - JR Rahn - LSD, ADHD, and Decriminalization
from Psychedelics Today
In this episode, Joe interviews founder and CEO of MindMed, JR Rahn. They discuss decriminalization, the DEA, ADHD, Xanax, and MindMed's goals: developing a trip-neutralizing drug and studying microdosing LSD for adult ADHD. www.psychedelicstoday.com
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Psychedelics Today?
This episode is 1 hour and 14 minutes long.
When was this Psychedelics Today episode published?
This episode was published on March 2, 2021.
Can I download this Psychedelics Today episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.